By combining a targeted in vivo shRNA screen followed by survival studies in patient derived xenograft mouse models, we uncovered the importance of several key glycolytic enzymes including PFK1, PDK1, PGAM 1 and ENO1 for intracranial growth of GBM. The gene discussed is PFKM; the disease is glioblastoma.